Skip to main content

Table 1 Baseline sociodemographic and biobehavioral characteristics of WIHS participants

From: Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Factor

N = 2601

Socio-demographic and study characteristics

Median age (IQR)

40.5 (34.5, 47.1)

Race/ethnicity

 African American, non-Hispanic

1632 (63)

 Latina/Hispanic

574 (22)

 White, non-Hispanic

317 (12)

 Asian/Pacific Islander/Native American or Alaskan/Other

78 (3)

Enrollment wave

 Wave 1: 1994–1995

1230 (47)

 Wave 2: 2001–2002

617 (24)

 Wave 3: 2011–2012

230 (8)

 Wave 4: 2013–2015

524 (20)

Less than high school education

949 (36)

Married or partnered

863 (33)

Unstable housing

140 (5)

Unemployed

1754 (67)

Annual household income ≤$24,000

2057 (79)

No health insurance

241 (9)

Pregnant in past 6 months

114 (4)

Mental Health

Depressive symptoms (CES-D score ≥ 16)

1043 (40)

Substance Use

Current smoker

1196 (46)

Alcohol use

 None

1401 (54)

 Low (> 0–7 drinks per week)

965 (37)

 Moderate (> 7–12 drinks per week)

97 (4)

 Heavy (> 12 drinks per week)

138 (5)

Non-injection drug use

617 (24)

Injection drug use

 Never

2018 (78)

 Former

528 (20)

 Current

55 (2)

Medical injection experience

 Insulin use (medical injection)

  Never

2525 (97)

  Former

15 (1)

  Current

61 (2)

 Depo medroxyprogesterone acetate use (medical injection)

  Never

2300 (88)

  Former

156 (6)

  Current

145 (6)

Adherence and viral suppression

  ≥ 75% adherence reported

2135 (82)

 HIV RNA ≤80 copies/ml

1370 (53)